When Less Is More: Reevaluating the Role of Intensive Chemotherapy for Older Adults With Acute Myeloid Leukemia in the Modern Era

被引：8
|
作者：
Short, Nicholas J. [1 ]
Kantarjian, Hagop [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd,Unit 428, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 28期
关键词：
AML PATIENTS; OUTCOMES; AZACITIDINE; PATTERNS; DECISION; CARE; AGE;
D O I：
10.1200/JCO.21.00960
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3104 / +
页数：6
相关论文
共 50 条
  • [21] Intensive Chemotherapy for Acute Myeloid Leukemia in Elderly Patients
    Jackson, Kathryn A.
    Kennedy, Glen A.
    Mollee, Peter
    Morris, Kirk
    BLOOD, 2012, 120 (21)
  • [22] Defining and Treating Older Adults with Acute Myeloid Leukemia who Are ineligible for intensive Therapies
    Pettit, Kristen
    Odenike, Olatoyosi
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [23] Commentary: dose intensive chemotherapy in acute myeloid leukemia
    Feldman, EJ
    LEUKEMIA RESEARCH, 2001, 25 (03) : 217 - 219
  • [24] Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission
    Slavin, Samuel D.
    Fenech, Alyssa
    Jankowski, Amanda L.
    Abel, Gregory A.
    Brunner, Andrew M.
    Steensma, David P.
    Fathi, Amir T.
    DeAngelo, Daniel J.
    Wadleigh, Martha
    Hobbs, Gabriela S.
    Amrein, Philip C.
    Stone, Richard M.
    Temel, Jennifer S.
    El-Jawahri, Areej
    CANCER, 2019, 125 (21) : 3845 - 3852
  • [25] Prediction of survival with intensive chemotherapy in acute myeloid leukemia
    Sasaki, Koji
    Ravandi, Farhad
    Kadia, Tapan
    DiNardo, Courtney
    Borthakur, Gautam
    Short, Nicholas
    Jain, Nitin
    Daver, Naval
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Khoury, Joseph
    Konoplev, Sergej
    Loghavi, Sanam
    Patel, Keyur
    Montalban-Bravo, Guillermo
    Masarova, Lucia
    Konopleva, Marina
    Kantarjian, Hagop
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (07) : 865 - 876
  • [26] Treating acute myeloid leukemia in the modern era: A primer
    Blum, William G.
    Mims, Alice S.
    CANCER, 2020, 126 (21) : 4668 - 4677
  • [27] Frontline Selinexor and Chemotherapy Is Highly Active in Older Adults with Acute Myeloid Leukemia (AML)
    Pardee, Timothy S.
    Pladna, Kristin M.
    Lyerly, Susan
    Dralle, Sarah
    Manuel, Megan
    Ellis, Leslie Renee
    Howard, Dianna S.
    Bhave, Rupali
    Powell, Bayard L.
    BLOOD, 2020, 136
  • [28] Frontline treatment patterns and outcomes among older adults with acute myeloid leukemia: A population-based analysis in the modern era
    Kennedy, Vanessa E.
    Keegan, Theresa H. M.
    Li, Qian
    Maguire, Frances B.
    Muffly, Lori S.
    CANCER, 2022, 128 (01) : 139 - 149
  • [29] Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia
    Dumas, Pierre-Yves
    Bertoli, Sarah
    Berard, Emilie
    Mediavilla, Clemence
    Yon, Edwige
    Tavitian, Suzanne
    Leguay, Thibaut
    Huguet, Francoise
    Forcade, Edouard
    Milpied, Noel
    Sarry, Audrey
    Sauvezie, Mathieu
    Bories, Pierre
    Pigneux, Arnaud
    Recher, Christian
    ONCOTARGET, 2017, 8 (45) : 79126 - 79136
  • [30] Intensive Chemotherapy in Patients Aged 70 Years or Older Newly Diagnosed With Acute Myeloid Leukemia
    Ross, Kelly
    Gillespie-Twardy, Amanda L.
    Agha, Mounzer
    Raptis, Anastasios
    Hou, Jing-Zhou
    Farah, Rafic
    Redner, Robert L.
    Im, Annie
    Duggal, Shrina
    Ding, Fei
    Lin, Yan
    Boyiadzis, Michael
    ONCOLOGY RESEARCH, 2014, 22 (02) : 85 - 92
12345